Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment. (Q46901919)
Jump to navigation
Jump to search
scientific article published on 13 November 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment. |
scientific article published on 13 November 2007 |
Statements
Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment (English)
Kurt Højlund
Henning Beck-Nielsen
13 November 2007